Related Experiment Video
Updated: May 23, 2025

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
Published on: November 18, 2022
Advancing type 1 diabetes treatment: A breakthrough in stem cell therapy
Zainab Anfaal1, Zmarak Ahmed Khan1
1Department of Medicine, Khyber Medical College, Peshawar, Khyber Pakhtunkhwa 25120, Pakistan.
Chemically induced pluripotent stem cell-derived islets offer a promising new treatment for type 1 diabetes. This regenerative therapy achieved insulin independence in a patient, potentially reducing the need for lifelong insulin injections.
Area of Science:
- Regenerative Medicine
- Endocrinology
- Immunology
Background:
- Type 1 diabetes is an autoimmune disease causing insulin deficiency.
- Current management relies on intensive insulin therapy.
- Significant need for advanced therapeutic strategies exists.
Related Concept Videos
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Stem Cell Culture
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

